{"entity":{"type":"insider","cik":"0001313876","url":"/insider/0001313876","json_url":"/insider/0001313876.json","name":"RICHMAN ERIC I","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":14,"first":"2010-06-21","last":"2024-07-01","span_basis":"filed_date"},"name_variants":[{"name":"RICHMAN ERIC I","source":"filing","n_filings":14,"first_seen":"2010-06-21","last_seen":"2024-07-01"}],"transactions":[{"id":2286826,"accession":"0001493152-24-025831","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-24-025831","line_url":"/filing/0001493152-24-025831","is_derivative":false,"issuer_cik":"0001313876","issuer_name":"Gain Therapeutics, Inc.","issuer_ticker":"GANX","issuer_name_source":null,"issuer_url":"/issuer/0001313876","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17000.0,"shares_display":"17,000","price_per_share":1.2158823529411764,"price_display":"1.22","price_state":"stated","total_value":20670.0,"total_display":"20,670.00","total_whole":"20,670","shares_owned_after":289629.0,"shares_owned_after_display":"289,629","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-01","scope":"insider","n_lines":2},{"id":6505768,"accession":"0001415889-22-005798","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-005798","line_url":"/filing/0001415889-22-005798#line-1","is_derivative":false,"issuer_cik":"0001313876","issuer_name":"Gain Therapeutics, Inc.","issuer_ticker":"GANX","issuer_name_source":null,"issuer_url":"/issuer/0001313876","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2482.0,"shares_display":"2,482","price_per_share":2.58,"price_display":"2.58","price_state":"stated","total_value":6403.56,"total_display":"6,403.56","total_whole":"6,404","shares_owned_after":217729.0,"shares_owned_after_display":"217,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-27","scope":"insider"},{"id":6904852,"accession":"0001415889-22-005501","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-005501","line_url":"/filing/0001415889-22-005501#line-2","is_derivative":false,"issuer_cik":"0001313876","issuer_name":"Gain Therapeutics, Inc.","issuer_ticker":"GANX","issuer_name_source":null,"issuer_url":"/issuer/0001313876","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9256.0,"shares_display":"9,256","price_per_share":2.83,"price_display":"2.83","price_state":"stated","total_value":26194.48,"total_display":"26,194.48","total_whole":"26,194","shares_owned_after":215247.0,"shares_owned_after_display":"215,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-23","scope":"insider"},{"id":6904846,"accession":"0001415889-22-005501","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-005501","line_url":"/filing/0001415889-22-005501#line-1","is_derivative":false,"issuer_cik":"0001313876","issuer_name":"Gain Therapeutics, Inc.","issuer_ticker":"GANX","issuer_name_source":null,"issuer_url":"/issuer/0001313876","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":2.71,"price_display":"2.71","price_state":"stated","total_value":10840.0,"total_display":"10,840.00","total_whole":"10,840","shares_owned_after":205991.0,"shares_owned_after_display":"205,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-23","scope":"insider"},{"id":6536851,"accession":"0001104659-22-031172","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-031172","line_url":"/filing/0001104659-22-031172#line-3","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"NeuBase Therapeutics, Inc.","issuer_ticker":"NBSE","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.62,"price_display":"1.62","price_state":"stated","total_value":1620.0,"total_display":"1,620.00","total_whole":"1,620","shares_owned_after":44960.0,"shares_owned_after_display":"44,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-04","filed_date":"2022-03-07","scope":"insider"},{"id":6536848,"accession":"0001104659-22-031172","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-031172","line_url":"/filing/0001104659-22-031172#line-2","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"NeuBase Therapeutics, Inc.","issuer_ticker":"NBSE","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1300.0,"shares_display":"1,300","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":2236.0,"total_display":"2,236.00","total_whole":"2,236","shares_owned_after":43960.0,"shares_owned_after_display":"43,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-07","scope":"insider"},{"id":6536846,"accession":"0001104659-22-031172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-031172","line_url":"/filing/0001104659-22-031172#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"NeuBase Therapeutics, Inc.","issuer_ticker":"NBSE","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1580.0,"shares_display":"1,580","price_per_share":1.58,"price_display":"1.58","price_state":"stated","total_value":2496.4,"total_display":"2,496.40","total_whole":"2,496","shares_owned_after":42660.0,"shares_owned_after_display":"42,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-07","scope":"insider"},{"id":9271739,"accession":"0001209191-22-025180","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-025180","line_url":"/filing/0001209191-22-025180#line-1","is_derivative":false,"issuer_cik":"0001313876","issuer_name":"Gain Therapeutics, Inc.","issuer_ticker":"GANX","issuer_name_source":null,"issuer_url":"/issuer/0001313876","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4922.0,"shares_display":"4,922","price_per_share":7.866,"price_display":"7.87","price_state":"stated","total_value":38716.452,"total_display":"38,716.45","total_whole":"38,716","shares_owned_after":216820.0,"shares_owned_after_display":"216,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2022-04-21","scope":"insider"},{"id":4514351,"accession":"0001104659-21-055582","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-055582","line_url":"/filing/0001104659-21-055582#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"NeuBase Therapeutics, Inc.","issuer_ticker":"NBSE","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","total_whole":"25,000","shares_owned_after":41080.0,"shares_owned_after_display":"41,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-26","filed_date":"2021-04-27","scope":"insider"},{"id":2518882,"accession":"0001104659-20-055957","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-055957","line_url":"/filing/0001104659-20-055957","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"NeuBase Therapeutics, Inc.","issuer_ticker":"NBSE","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10833.0,"shares_display":"10,833","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":64998.0,"total_display":"64,998.00","total_whole":"64,998","shares_owned_after":36080.0,"shares_owned_after_display":"36,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-30","filed_date":"2020-05-04","scope":"insider","n_lines":2},{"id":6123389,"accession":"0001193805-18-000817","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-18-000817","line_url":"/filing/0001193805-18-000817#line-1","is_derivative":false,"issuer_cik":"0001313876","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001313876","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5230.0,"shares_display":"5,230","price_per_share":4.78,"price_display":"4.78","price_state":"stated","total_value":24999.4,"total_display":"24,999.40","total_whole":"24,999","shares_owned_after":36530.0,"shares_owned_after_display":"36,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-11","scope":"insider"},{"id":4732009,"accession":"0001193805-17-003455","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-17-003455","line_url":"/filing/0001193805-17-003455#line-1","is_derivative":false,"issuer_cik":"0001313876","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001313876","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":53750.0,"total_display":"53,750.00","total_whole":"53,750","shares_owned_after":31300.0,"shares_owned_after_display":"31,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-09","filed_date":"2017-11-13","scope":"insider"},{"id":2565768,"accession":"0001144204-16-094715","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001144204-16-094715","line_url":"/filing/0001144204-16-094715","is_derivative":false,"issuer_cik":"0001313876","issuer_name":"PHARMATHENE, INC","issuer_ticker":"PIP","issuer_name_source":null,"issuer_url":"/issuer/0001313876","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":329354.0,"shares_display":"329,354","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":724578.8,"total_display":"724,578.80","total_whole":"724,579","shares_owned_after":176822.0,"shares_owned_after_display":"176,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-13","filed_date":"2016-04-15","scope":"insider","n_lines":4},{"id":2889425,"accession":"0001144204-16-093743","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-16-093743","line_url":"/filing/0001144204-16-093743#line-4","is_derivative":false,"issuer_cik":"0001313876","issuer_name":"PHARMATHENE, INC","issuer_ticker":"PIP","issuer_name_source":null,"issuer_url":"/issuer/0001313876","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6400.0,"shares_display":"6,400","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":14080.0,"total_display":"14,080.00","total_whole":"14,080","shares_owned_after":176822.0,"shares_owned_after_display":"176,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-08","filed_date":"2016-04-11","scope":"insider"},{"id":2889415,"accession":"0001144204-16-093743","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-093743","line_url":"/filing/0001144204-16-093743#line-2","is_derivative":false,"issuer_cik":"0001313876","issuer_name":"PHARMATHENE, INC","issuer_ticker":"PIP","issuer_name_source":null,"issuer_url":"/issuer/0001313876","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5367.0,"shares_display":"5,367","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":11807.4,"total_display":"11,807.40","total_whole":"11,807","shares_owned_after":176822.0,"shares_owned_after_display":"176,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-07","filed_date":"2016-04-11","scope":"insider"},{"id":8686150,"accession":"0001193805-15-000386","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-15-000386","line_url":"/filing/0001193805-15-000386","is_derivative":false,"issuer_cik":"0001313876","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001313876","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":7.877142857142857,"price_display":"7.88","price_state":"stated","total_value":27570.0,"total_display":"27,570.00","total_whole":"27,570","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-13","filed_date":"2015-03-17","scope":"insider","n_lines":2},{"id":9120637,"accession":"0001144204-11-063358","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-11-063358","line_url":"/filing/0001144204-11-063358","is_derivative":false,"issuer_cik":"0001313876","issuer_name":"PHARMATHENE, INC","issuer_ticker":"PIP","issuer_name_source":null,"issuer_url":"/issuer/0001313876","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.502475,"price_display":"1.50","price_state":"stated","total_value":15024.75,"total_display":"15,024.75","total_whole":"15,025","shares_owned_after":4500.0,"shares_owned_after_display":"4,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-11-10","filed_date":"2011-11-14","scope":"insider","n_lines":3},{"id":7215513,"accession":"0001144204-10-034419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-10-034419","line_url":"/filing/0001144204-10-034419#line-1","is_derivative":false,"issuer_cik":"0001313876","issuer_name":"PHARMATHENE, INC","issuer_ticker":"PIP","issuer_name_source":null,"issuer_url":"/issuer/0001313876","owner_cik":"0001313876","owner_name":"RICHMAN ERIC I","owner_display_name":"RICHMAN ERIC I","owner_url":"/insider/0001313876","role":"Director, Officer (President and Interim CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Interim CEO","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.5767,"price_display":"1.58","price_state":"stated","total_value":15767.0,"total_display":"15,767.00","total_whole":"15,767","shares_owned_after":70573.0,"shares_owned_after_display":"70,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-17","filed_date":"2010-06-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":20,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001819411","name":"Gain Therapeutics, Inc.","url":"/issuer/0001819411","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","n_filings":4,"first_seen":"2022-04-21","last_seen":"2024-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001173281","name":"NeuBase Therapeutics, Inc.","url":"/issuer/0001173281","role":"Director","n_filings":3,"first_seen":"2020-05-04","last_seen":"2022-03-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001368514","name":"ADMA BIOLOGICS, INC.","url":"/issuer/0001368514","role":"Director","n_filings":3,"first_seen":"2015-03-17","last_seen":"2018-06-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001326190","name":"PHARMATHENE, INC","url":"/issuer/0001326190","role":"Director, Officer (President and CEO)","n_filings":4,"first_seen":"2010-06-21","last_seen":"2016-04-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001313876","retrieved_at":"2026-08-25T09:49:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}